Medical Sciences
OPEN ACCESS
Management Of A Patient With A Rare Variant Of Autoimmune Polyglandular Syndrome Of The Second Type
DOI
Crossref DOI
10.37547/TAJMSPR/Volume02Issue07-04
tajmspr
2020
VOL. 2
/ NO. 07
JULY
RESEARCH OVERVIEW
Abstract
The article considers a clinical case of a young patient with autoimmune polyglandular
syndrome type 2, represented by type 1 diabetes mellitus, thyroid dysfunction and
primary adrenal cortex insufficiency.
RESEARCH TOPICS
Keywords
autoimmune polyglandular syndrome type 2,
type 1 diabetes mellitus
Downloads
Download data is not yet available.
SOURCES & SCHOLARSHIP
References
- Betterle C., Zanchetta R. Update on autoimmune polyendocrine syndromes (APS).
- Clinical Immunology and Allergology. Acta Bio Medica 2003; 74: 1: 9-33.
- Kahaly G.J. Polyglandular autoimmune syndromes. Eur J Endocrinol 2009; 161: 1: 11-
- doi: 10.1530/eje-09-0044.
- Endocrinology. National leadership. Edited By I. I. Dedov, G. A. Melnichenko. M:
- GEOTAR-Media, 2008.
- Yu. I. Klyuchagina1, Z. A. Sokolova2, M. A. Baryshnikov2. The role of the PD-1 receptor
- and its PDL1 and PDL2 ligands in tumor immunotherapy. Oncopediatrics. 2017, 4 (1) 49-
- pages.
- L. Tsarev , A.V. Melerzanov, Review of approaches to immunotherapy in Oncology.
- Journal of Research and practice in medicine 2017, vol. 4, no. 3, pp. 51-65 REVIEW DOI: